Status:

COMPLETED

Randomized Control Trial to Assess Postoperative Pain After Sling Placement

Lead Sponsor:

University of North Carolina, Chapel Hill

Conditions:

Stress Urinary Incontinence

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

There are many ways to perform a suprapubic approach pubovaginal sling. Some surgeons inject local pain medical into the retropubic space before placing the sling, others do not. This study is to dete...

Detailed Description

To evaluate if an injection in the retropubic space with a local acting anesthetic, Marcaine, (bupivacaine) at the time of mid-urethral sling placement will improve patients' reported post operative p...

Eligibility Criteria

Inclusion

  • Any female patient, age 18 or older, who elects to have a mid-urethral sling with or without an anterior or posterior repair at the University of North Carolina Hospitals by a member of the Division of Urogynecology.

Exclusion

  • Any patient with a chronic pain syndrome, a contraindication to nonsteroidal anti-inflammatory drugs (NSAIDs) such as liver disease, abnormal coagulation, esophageal disorders or peptic ulcers or where pain evaluation is unreliable because of neurological disease and those on treatment with steroids/NSAIDs/opioids prior to surgery.
  • Also excluded will be any patient who is having any other reconstructive pelvic surgery concomitantly or would require the placement of a suprapubic catheter.
  • Patients electing to have their surgery with regional anesthesia, such as an epidural or spinal will be excluded.
  • All minors, decisional impaired people, nursing mothers and non-English speaking people will be excluded.

Key Trial Info

Start Date :

January 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2009

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT00746863

Start Date

January 1 2007

End Date

September 1 2009

Last Update

June 22 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599